Package Leaflet: Information for the User
Ibuprofeno Pharmaclan 600 mgfilm-coated tablets EFG
Ibuprofeno Pharmaclan contains the active substance ibuprofen, which belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
Ibuprofen is used for the symptomatic treatment of pain and inflammation in arthritic diseases (e.g., rheumatoid arthritis), degenerative arthritic conditions (e.g., osteoarthritis), and painful swelling and inflammation after soft tissue injuries.
Ibuprofeno Pharmaclan 600 mg film-coated tablets are indicated in adults and adolescents with a body weight of at least 50 kg (from 15 years of age onwards).
if you have ever had bleeding or perforation in the stomach or intestine related to previous treatment with an NSAID.
Consult your pharmacist or doctor:
The risk of side effects increases with increasing dose of the product and in elderly people. Therefore, treatment should be initiated with the lowest possible dose and continued for the shortest time necessary to treat the symptoms.
Ibuprofen may mask signs of infection, such as fever and pain. Therefore, Ibuprofeno Pharmaclan may delay appropriate treatment of the infection, which may lead to a higher risk of complications. This has been observed in bacterial pneumonia and bacterial skin infections related to chickenpox. If you take this medicine while having an infection and your infection symptoms persist or worsen, consult a doctor without delay.
Anti-inflammatory/pain-relieving medicines like ibuprofen may be associated with a small increased risk of heart attack (myocardial infarction) or stroke, especially when used at high doses. Do not exceed the recommended dose or duration of treatment.
You should discuss your treatment with your doctor or pharmacist before taking ibuprofen if:
The combined use of Ibuprofeno Pharmaclan with other non-steroidal anti-inflammatory drugs (NSAIDs), including so-called COX-2 inhibitors (cyclooxygenase-2 inhibitors), should be avoided.
Gastrointestinal bleeding, ulcers, and perforations:
With all NSAIDs, gastrointestinal bleeding, ulcers, and perforations have been reported, sometimes with fatal outcomes. These have occurred at any time during therapy, with or without prior warning symptoms or history of serious gastrointestinal events.
The risk of experiencing gastrointestinal bleeding, ulcers, and perforation is higher with increasing doses of the NSAID and is higher in patients with a history of ulcers, especially with complications of bleeding or perforation (see section 2 "Do not take Ibuprofeno Pharmaclan") and in elderly patients. These patients should start treatment with the lowest available dose. For these patients, as well as for patients who require additional treatment with low doses of acetylsalicylic acid or other medications that may increase the risk of gastrointestinal disorders, combination therapy with protective medications (e.g., misoprostol or proton pump inhibitors) is recommended.
If you have a history of side effects that affect the gastrointestinal tract, especially if you are an elderly person, you should consult a doctor in case of unusual abdominal symptoms (especially gastrointestinal bleeding), particularly at the start of treatment.
Cautious use is recommended if you are also taking other medications that may increase the risk of ulcers or bleeding, e.g., oral corticosteroids, anticoagulants (blood thinners) such as warfarin, selective serotonin reuptake inhibitors (used to treat psychiatric disorders, including depression) or platelet aggregation inhibitors such as acetylsalicylic acid (see section 2 "Other medicines and Ibuprofeno Pharmaclan").
Treatment should be discontinued and a doctor consulted if you develop gastrointestinal bleeding or ulcers during treatment with Ibuprofeno Pharmaclan.
Severe skin reactions have been reported with Ibuprofeno Pharmaclan. You should stop taking Ibuprofeno Pharmaclan and seek immediate medical attention if you develop any skin rash, mucosal lesions, blisters, or other signs of allergy, as these can be the first signs of a severe skin reaction. See section 4.
Other warnings
Very rarely, severe acute hypersensitivity reactions (e.g., anaphylactic shock) have been observed. At the first signs of a hypersensitivity reaction after taking Ibuprofeno Pharmaclan, treatment should be discontinued and a doctor consulted. Medically necessary measures, according to symptoms, should be initiated by a healthcare professional.
Ibuprofen may temporarily inhibit platelet function (platelet aggregation). Therefore, patients with blood clotting disorders should be carefully monitored.
Prolonged use of any type of pain reliever for headaches may worsen them. If this situation is experienced or suspected, medical advice should be sought and treatment discontinued. The diagnosis of medication-overuse headache (MOH) should be suspected in patients who have frequent or daily headaches despite (or due to) regular use of headache medications.
During prolonged use of ibuprofen, regular monitoring of liver function tests, kidney function, and blood counts is required.
In general, the habitual intake of pain relievers, especially when combining several pain relievers, can lead to permanent kidney damage. This risk may increase under physical exertion associated with salt loss and dehydration. Therefore, it should be avoided.
There is a risk of kidney failure in dehydrated adolescents.
Ibuprofeno Pharmaclan 600 mg is not intended for adolescents who weigh less than 50 kg or for children and adolescents under 15 years of age.
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Ibuprofeno Pharmaclan may affect or be affected by other medicines. For example:
digoxin (used to treat various heart conditions), as the effect of digoxin may be enhanced. Monitoring of digoxin serum levels is recommended.
It is necessary to monitor lithium serum levels.
Monitoring of phenytoin serum levels is recommended.
Some other medicines may also affect or be affected by the treatment of Ibuprofeno Pharmaclan. Therefore, you should always consult your doctor or pharmacist before using Ibuprofeno Pharmaclan with other medicines.
Avoid drinking alcohol, as it may enhance the side effects of this medicine, especially those affecting the stomach, intestines, or brain.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Pregnancy
If you have taken this medicine while pregnant, you should immediately talk to your doctor/midwife so that appropriate follow-up can be considered.
Breastfeeding
Only small amounts of ibuprofen pass into breast milk, and it is generally not necessary to interrupt breastfeeding during short-term use of ibuprofen at the recommended dose for fever and pain. However, if prolonged treatment or higher doses are prescribed, early weaning should be considered.
Fertility
Ibuprofeno Pharmaclan may make it more difficult to become pregnant. You should inform your doctor if you are planning to become pregnant or if you are having trouble becoming pregnant.
The product belongs to a group of medicines (NSAIDs) that may affect fertility in women. This effect is reversible upon discontinuation of the medicine.
Generally, the influence of ibuprofen on the ability to drive and use machines is negligible or minimal. However, since higher doses may cause adverse reactions on the central nervous system, such as fatigue and dizziness, in individual cases, the ability to react and actively participate in driving and using machines may be impaired. This applies to a greater extent in combination with alcohol.
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet, i.e., it is essentially 'sodium-free'.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
The effective lowest dose should be used for the shortest time necessary to relieve symptoms. If you have an infection, consult a doctor immediately if the symptoms (such as fever and pain) persist or worsen (see section 2).
DOSAGE:
The single maximum dose should not exceed 600 mg of ibuprofen for adolescents and adults with a body weight of at least 50 kg (from 15 years of age onwards).
The recommended dose is 1200-1800 mg per day in divided doses. Allow at least 6 hours between doses. Your doctor may prescribe lower doses. Due to the nature and severity of your condition, your doctor may choose to increase your medication to one 600 mg tablet, taken 4 times a day. The maximum daily dose should not exceed 2400 mg in a 24-hour period.
The recommended daily dose is 20 mg/kg up to a maximum of 40 mg/kg of body weight, divided into 3-4 partial doses. Allow at least 6 hours to pass between doses. The total daily maximum dose should not exceed 2400 mg in a 24-hour period.
Use in children and adolescents
The dose of ibuprofen in adolescents depends on the patient's age and body weight.
Ibuprofeno Pharmaclan 600 mg is not intended for adolescents who weigh less than 50 kg or for children and adolescents under 15 years of age.
Advanced age
If you are an elderly person, you should always consult your doctor before using Ibuprofeno Pharmaclan. You will be more prone to suffering side effects, especially bleeding and perforation in the gastrointestinal tract, which can be fatal. Your doctor will advise you accordingly.
Reduced hepatic or renal function
If you have reduced renal or hepatic function, always consult a doctor before using Ibuprofeno Pharmaclan. Do not take this medication if you have severe hepatic or renal failure.
Method of administration
Ibuprofeno Pharmaclan is for oral use.
Take the tablets with a glass of water. The tablets should be swallowed whole, without biting, crushing, breaking, or sucking to avoid discomfort in the mouth or throat irritation.
Patients with sensitive stomachs are recommended to take the tablets with meals. If taken shortly after eating, the onset of action of ibuprofen may be delayed.
Duration of treatment:
The duration of treatment is determined by the treating physician.
In rheumatic diseases, it may be necessary to take ibuprofen for a prolonged period.
If you have taken more ibuprofen than you should, or if children have taken this medication by accident, always contact a doctor or the nearest hospital to obtain an opinion on the risk and advice on the measures to be taken.
Symptoms may include nausea, stomach pain, vomiting (which may have blood streaks) or, more rarely, diarrhea. Additionally, headache, gastrointestinal bleeding, blurred vision, ringing in the ears, confusion, and tremulous eye movements, and exacerbation of asthma in asthmatics. At high doses, somnolence, excitement, disorientation, chest pain, palpitations, loss of consciousness, convulsions (mainly in children), dizziness, weakness, and dizziness, blood in the urine, low blood pressure, hyperkalemia, metabolic acidosis, increased prothrombin time/INR, acute renal failure, liver damage, respiratory depression, cyanosis, feeling of cold in the body, and respiratory problems have been reported.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Do not take a double dose to make up for missed doses.
If you have any further questions on the use of this medication, consult your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone will experience them. You can minimize the risk of side effects by taking the lowest effective dose for the shortest time necessary to control your symptoms.
Regarding the following side effects, it should be considered that they depend largely on the dose and vary from patient to patient.
The most frequently observed side effects are of a gastrointestinal nature. Peptic ulcers, perforation, or gastrointestinal bleeding, sometimes fatal, especially in the elderly, may occur. After administration, nausea, vomiting, diarrhea, flatulence, constipation, indigestion, abdominal pain, melena, hematemesis, ulcerative stomatitis, exacerbation of colitis, and Crohn's disease have been reported. Less frequently, inflammation of the stomach lining (gastritis) has been observed.
Medications like ibuprofen may be associated with a small increased risk of heart attack (myocardial infarction) or stroke. Cases of water retention (edema), high blood pressure, and heart failure have been reported in association with NSAIDs.
STOP TAKING Ibuprofeno Pharmaclan and contact a doctor immediately if you experience any of these symptoms:
Very common (may affect more than 1 in 10 people)
If you experience any type of side effect, consult your doctor or pharmacist. Even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and any unused medication in the pharmacy's SIGRE collection point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.
The active ingredient is ibuprofen. Each film-coated tablet contains 600 mg of ibuprofen.
The other ingredients are: tablet core: microcrystalline cellulose 102, pregelatinized starch (prepared from corn starch), povidone K 90, sodium lauryl sulfate, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate, film coating: hypromellose 2910, hydroxypropylcellulose, macrogol 400, titanium dioxide (E171).
Film-coated tablets, white to off-white in color, capsule-shaped, with the inscription 'I7' on one side and smooth on the other. The tablet dimensions are approximately 17.19 mm x 9.23 mm and the thickness is 6.60 mm.
Transparent PVC/Aluminum blister pack in an outer cardboard box containing 10 or 12 tablets per blister.
Package sizes:
20, 24, 30, 40, 50, 100 tablets.
Not all package sizes may be marketed.
Pharmaclan s.r.o.
Trtinová 260/1, Cakovice
196 00, Prague 9
Czech Republic
Manufacturer:
Pharmazet Group s.r.o.
Trtinová 260/1, Cakovice
196 00, Prague 9
Czech Republic
Czech Republic | Ibuprofen Pharmaclan 600 mg potahované tablety |
Spain | Ibuprofeno Pharmaclan 600 mg comprimidos recubiertos con película EFG |
Germany | Ibuprofen Pharmaclan 600 mg Filmtabletten |
Poland | Ibuprofen Pharmaclan 600 mg tabletki powlekane |
Finland | Ibuprofen Pharmaclan 600 mg kalvopäällystetyt tabletit |
France | Ibuprofène Pharmaclan 600 mg comprimé pelliculé |
November 2023
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es